KA
KERX

Kovack Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Kovack Advisors’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-12,600
Closed -$52K – 531
2018
Q1 		$52K Buy
12,600
+1,000
+9% +$4.13K 0.01% 460
2017
Q4 		$54K Buy
+11,600
New +$54K 0.01% 446